Skip to main content
Erschienen in: International Urogynecology Journal 10/2017

24.02.2017 | Original Article

Suburethral sling procedures in the United States: complications, readmission, and reoperation

verfasst von: Katie Propst, David M. O’Sullivan, Paul K. Tulikangas

Erschienen in: International Urogynecology Journal | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Hospital readmission is increasingly used as a measure of quality care. Our objective was to evaluate the rate of readmission and associated factors in women undergoing suburethral sling placement in the USA.

Methods

This is a cohort study of suburethral sling procedures performed in the USA from 2012 to 2014 using the American College of Surgeons’ National Surgical Quality Improvement Program database. The database was queried for suburethral sling procedures. Records were excluded if concomitant surgery had been performed. Patient and surgical characteristics were evaluated for association with readmission using Chi-squared test for categorical variables and Student’s t test for continuous variables. All results yielding p < 0.05 were deemed statistically significant.

Results

A total of 7,117 suburethral sling procedures were identified. There were 83 (1.16%) hospital readmissions. Those who were readmitted tended to be older (p = 0.011), non-Hispanic (p = 0.04), smokers (p < 0.001), and have an American Society of Anesthesiologists Physical Status Classification System score of 3 or 4 (p = 0.001). A history of bleeding disorder (p < 0.001), congestive heart failure (p < 0.001), or chronic obstructive pulmonary disease (p < 0.001) was associated with readmission. Fifty-four (0.75%) patients underwent reoperation within 30 days of suburethral sling placement. The most common reoperation procedure was sling excision (20 patients). The most common complication was urinary tract infection, which occurred in 189 patients (2.7%).

Conclusions

Suburethral sling placement is a safe procedure with a low rate of readmissions, reoperations, and complications. Consistent with other types of surgery, infection is the most common post-operative complication.
Literatur
3.
Zurück zum Zitat Barber MD, Gustilo-Ashby AM, Chen CCG, Kaplan P, Paraiso MFR, Walters MD. Perioperative complications and adverse events of the MONARC transobturator tape, compared with the tension-free vaginal tape. Am J Obstet Gynecol. 2006;195(6):1820–5.CrossRefPubMed Barber MD, Gustilo-Ashby AM, Chen CCG, Kaplan P, Paraiso MFR, Walters MD. Perioperative complications and adverse events of the MONARC transobturator tape, compared with the tension-free vaginal tape. Am J Obstet Gynecol. 2006;195(6):1820–5.CrossRefPubMed
4.
Zurück zum Zitat Brubaker L, Norton PA, Albo ME, et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol. 2011;205(5):498.e1–6.CrossRef Brubaker L, Norton PA, Albo ME, et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol. 2011;205(5):498.e1–6.CrossRef
5.
Zurück zum Zitat Kuuva N, Nilsson CG. A nationwide analysis of complications associated with the tension-free vaginal tape (TVT) procedure. Acta Obstet Gynecol Scand. 2002;81:72–7.CrossRefPubMed Kuuva N, Nilsson CG. A nationwide analysis of complications associated with the tension-free vaginal tape (TVT) procedure. Acta Obstet Gynecol Scand. 2002;81:72–7.CrossRefPubMed
6.
Zurück zum Zitat Sultana CJ, Campbell JW, Pisanelli WS, Sivinski L, Rimm AA. Morbidity and mortality of incontinence surgery in elderly women: an analysis of Medicare data. Am J Obstet Gynecol. 1997;176(2):344–8.CrossRefPubMed Sultana CJ, Campbell JW, Pisanelli WS, Sivinski L, Rimm AA. Morbidity and mortality of incontinence surgery in elderly women: an analysis of Medicare data. Am J Obstet Gynecol. 1997;176(2):344–8.CrossRefPubMed
7.
Zurück zum Zitat Merkow RP, Ju MH, Chung JW, et al. Underlying reasons associated with hospital readmission following surgery in the United States. JAMA. 2015;313(5):483–95.CrossRefPubMed Merkow RP, Ju MH, Chung JW, et al. Underlying reasons associated with hospital readmission following surgery in the United States. JAMA. 2015;313(5):483–95.CrossRefPubMed
8.
Zurück zum Zitat Erekson EA, Lopes VV, Raker CA, Sung VW. Ambulatory procedures for female pelvic floor disorders in the United States. Am J Obstet Gynecol. 2010;203(5):497.e1–5.CrossRef Erekson EA, Lopes VV, Raker CA, Sung VW. Ambulatory procedures for female pelvic floor disorders in the United States. Am J Obstet Gynecol. 2010;203(5):497.e1–5.CrossRef
12.
Zurück zum Zitat Davé BA, Jaber C, Leader-Cramer A, et al. Effect of anesthesia type on perioperative outcomes with a midurethral sling. Int Urogynecol J. 2016;27(9):1327–32.CrossRefPubMed Davé BA, Jaber C, Leader-Cramer A, et al. Effect of anesthesia type on perioperative outcomes with a midurethral sling. Int Urogynecol J. 2016;27(9):1327–32.CrossRefPubMed
Metadaten
Titel
Suburethral sling procedures in the United States: complications, readmission, and reoperation
verfasst von
Katie Propst
David M. O’Sullivan
Paul K. Tulikangas
Publikationsdatum
24.02.2017
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 10/2017
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-017-3293-8

Weitere Artikel der Ausgabe 10/2017

International Urogynecology Journal 10/2017 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.